The state of cancer care in Russia: liver cancer - (C22). Age-related characteristics of morbidity and mortality, quality of registration, effectiveness of patient treatment. (Clinical population study). Part 1.

Cover Page


Cite item

Full Text

Abstract

A clinical-population study was conducted to identify patterns in the dynamics of incidence, mortality, and patient accounting for liver cancer in Russia, as well as the specifics of changes in the structure of affected individuals by detailed localization and age. Over an 11-year period, the incidence of liver cancer in Russia increased by 24.4%, while mortality rose by 9.6%. Special attention was paid to the nature of changes in age-specific incidence and mortality rates for the population of Russia with liver cancer. The aim of the study was to investigate the dynamics of key parameters of incidence, mortality, and the quality of primary patient accounting for liver cancer at the population level in Russia and the Northwestern Federal District of the Russian Federation. The study results confirmed the severity of the problem of this pathology and the challenges associated with the timely detection and provision of adequate care to patients with liver cancer. In some territories, the mortality rate from liver cancer exceeded the number of newly diagnosed patients by 2-3 times. The impact of the coronavirus infection pandemic on the quality of registration of liver cancer patients was also assessed. The study also presented modern possibilities for early diagnosis and treatment of patients with liver cancer.

About the authors

Vakhtang M. Merabishvili

N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: MVM@niioncologii.ru
ORCID iD: 0000-0002-1521-455X
SPIN-code: 5705-6327

Honored Scientist of the Russian Federation, Dr.Med.Sci., Professor, Head of the Department of Oncological Statistics,  Head of the PRR of the Northwestern Federal District of the Russian Federation

Russian Federation, Saint Petersburg

Sergey S. Bagnenko

N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Saint Petersburg State Pediatric Medical University

Email: bagnenko_ss@mail.ru
ORCID iD: 0000-0002-4131-6293
SPIN-code: 4389-9374
Scopus Author ID: 779096

M.D., D.Sc. (Medicine); Associated Professor, Head of Scientific Department, Leading researcher, Professor of the Department of Radiation Diagnostics and Biomedical Imaging 

Russian Federation, Saint Petersburg

Pavel V. Balakhnin

N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Email: balahnin_p@mail.ru
ORCID iD: 0000-0002-3042-6729
SPIN-code: 1431-4012

Ph.D., Senior Researcher of the Scientific Department of Diagnostic and Interventional Radiology, Head of the Department of X-ray Surgical Methods of Diagnostics and Treatment

Russian Federation, Санкт-Петербург

Ekaterina A. Busko

N.N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Saint Petersburg State University

Email: Katrn@mail.ru
ORCID iD: 0000-0002-0940-6491
SPIN-code: 7323-1083

DSc Med., Assoc. Prof., Leading researcher

Russian Federation, Saint Petersburg

References

  1. Cancer Incidence in Five Continents / [Elektronnyi resurs] // International Agency for Research on Cancer : [sait]. — URL: https://ci5.iarc.fr/ci5-xii/tables/summary
  2. Malignant neoplasms in Russia in 2022 (morbidity and mortality) / Kaprin A. D., Starinsky V. V., Shakhzadova A. O., Lisichnikova I. V. // Moscow: P. A. Hertsen MNIOI. – 2023. – 275 p. (in Russ).
  3. Merabishvili V. M., Gurkalo V. K., Merabishvili E. N. Morbidity, mortality and reliability of accounting of patients of different age groups with liver cancer in Russia // Advances in Gerontology. – 2020;33(2):240-245. (in Russ)
  4. Malignant neoplasms in Russia in 2000 (morbidity and mortality) / Chissov V. I., Starinsky V. V. // Moscow: P. A. Hertsen MNIOI. 2002:264. (in Russ).
  5. Malignant neoplasms in Russia in 2005 (morbidity and mortality) / Chissov V. I., Starinsky V. V. // Moscow: P.A. Hertsen MNIOI. 2007:252. (in Russ).
  6. Malignant neoplasms in Russia in 2010 (morbidity and mortality) / Chissov V. I., Starinsky V. V., Petrova G. V. // Moscow: P. A. Hertsen MNIOI. – 2012. – 260p. (in Russ).
  7. Malignant neoplasms in Russia in 2015 (morbidity and mortality) / Kaprin A. D., Starinsky V. V., Petrova G. V. // Moscow: P. A. Hertsen MNIOI. – 2017. – 250p. (in Russ).
  8. Malignant neoplasms in Russia in 2019 (morbidity and mortality) / Kaprin A. D., Starinsky V. V., Shakhzadova A. O. // Moscow: P. A. Hertsen MNIOI. – 2020. – 214p. (in Russ).
  9. Malignant neoplasms in Russia in 2020 (morbidity and mortality) / Kaprin A. D., Starinsky V. V, Shakhzadova A. O. // Moscow: P. A. Hertsen MNIOI. – 2021. – 252p. (in Russ).
  10. Malignant neoplasms in Russia in 2021 (morbidity and mortality) / Kaprin A. D., Starinsky V. V., Shakhzadova A. O. // Moscow: P. A. Hertsen MNIOI. – 2022. – 252p. (in Russ).
  11. Merabishvili V. M. Analytical indicators. accounting reliability index. // Voprosy Onkologii. 2018;64(3):445-452. (in Russ).
  12. Merabishvili V. M. The reliability index is the most important criterion for objective assessment of oncological service performance for all localisations of cancer, regardless of the level of mortality of patients. // Voprosy Onkologii. 2019;65(4):510-515. (in Russ).
  13. Merabishvili V. M., Belyaev A. M., Shcherbakov A. M. Malignant neoplasms in the North-West Federal District of Russia (morbidity, mortality, reliability of accounting, survival rate of patients). Express-information. 2020:236. (in Russ).
  14. Merabishvili V. M., Belyaev A. M. Malignant neoplasms in the North-West Federal District of Russia (morbidity, mortality, reliability of accounting, survival rate of patients). St. Petersburg. 2023:498. (in Russ).
  15. Merabishvili V. M. Covid and cancer in Russia. // Problems in Oncology. 2022; 68(4): 381–92. doi: 10.37469/0507-3758-2022-68-4-381-392. (in Russ).
  16. State of oncological care for the population of Russia in 2022. Kaprin A. D., Starinskiy V. V., Shakhzadova A. O., eds. Moscow: P.A. Herzen Moscow State Medical Research Institute - branch of the Federal State Budgetary Institution "NMRC of Radiology" of the Ministry of Health of Russia. 2022:239. (in Russ).
  17. Belyaev A. M., Merabishvili V. M. Methodological approaches to the analysis of the activities of the cancer service on the basis of the forms of state reporting and the database of the population cancer register of the northwestern Federal district. Part 1 // Problems in Oncology. 2019;63(5): 653-663. (in Russ).
  18. Merabishvili V. M. Oncology statistic. Part I. Second edition, expanded – Saarbrüchen, Dentschland (Germany): Lap Lambert Academic Publishing, 2015. (In Russ).
  19. Merabishvili V. M. Oncology statistic. Part II. Second edition, expanded – Saarbrüchen, Dentschland (Germany): Lap Lambert Academic Publishing, 2015. (In Russ).
  20. Merabishvili V. M. Analytical indicator. Analysis of the real state of dynamics of mortality of the population of Russia from malignant tumors and changes in its structure // Problems in Oncology. – 2018; 65(2): 205-219. (in Russ).
  21. Merabishvili V. M. regularities of the dynamics of age-specific cancer mortality indicators in Russian population // Advances in Gerontology. 2019; 32(3): 301-310. (in Russ).
  22. Merabishvili V. M., Merabishvili E. N., Chepik O. F. Epidemiology of liver cancer. morbidity, mortality, dynamics of histological structure. // Merabishvili V. M. Cancer Control in St. Petersburg (operative report for 2011–2012, precise elaboration of the Registry’s Database by international standards). The Populationbased Cancer Registry (IACR № 221), volume 18. Editors: V. M. Kolabutin, A. M. Belyaev. SPb.: KOSTA, 2013. P. 319-329; 329-335. (in Russ).
  23. Cancer Registration Principles and Methods / Ed. O. M. Jensen et al. // IARC Scientifi c Publ. 1991. № 95. Lyon.
  24. Mason W. S., Xu C., Aldrich C. E. et al. Hepatitus virus and liver cancer // Scientifi c Rep. Basic Sci. Med. Sci. Fox Chailds. Cancer cent. Philadelphia, 2004. P. 115–118.
  25. Statistical Methods in cancer research. Vol. 1. The analysis of case-control studies / Ed. N. E. Breslow et al. // IARC Scientifi c publ. 1980. № 32. Lyon.
  26. Khalaf N., Ying J., Mittal S., Temple S., Kanwal F., Davila J., El-Serag H.B. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clin Gastroenterol Hepatol. 2017; 15(2): 273-281.e1. doi: 10.1016/j.cgh.2016.07.033.
  27. Balakhnin P. V., Shmelev A. S., Shachinov E. G., Malkevich V. I. Etiology, screening and early diagnosis of hepatocellular carcinoma: Successes and new challenges related to the epidemic of obesity. // Prakticheskaja onkologija. 2019; 20(3): 179-202. doi: 10.31917/2003179. (in Russ).
  28. Schellhaas B. Et al. Contrast-enhanced ultrasound algorithms (CEUS-LIRADS/ESCULAP) for the noninvasive diagnosis of hepatocellular carcinoma–a prospective multicenter DEGUM study // Ultraschall in der Medizin-European Journal of Ultrasound. – 2021. – Т. 42. – №. 02. – С. 178-186.
  29. Trufanov G. E., Rud' S. D., Bagnenko S. S. Luchevaja diagnostika zabolevanij pecheni: normal'naja luchevaja anatomija pecheni, opisanie luchevoj semiotiki naibolee chasto vstrechajushhihsja zabolevanij i povrezhdenij pecheni, privoditsja differencial'naja diagnostika, taktika luchevogo issledovanija, voprosy jetiologii, patogeneza, morfologii klinicheskie projavlenija zabolevanij / Ser. Konspekt luchevogo diagnosta. Sankt-Peterburg: JeLBI-SPb, 2011. – 415 p. (in Russ).
  30. Bagnenko S. S., Trufanov G. E. MRT-diagnostika ochagovyh zabolevanij pecheni / Moskva: Obshhestvo s ogranichennoj otvetstvennost'ju Izdatel'skaja gruppa «GEOTAR-Media», 2017. – 128 p. – ISBN 978-5-9704-4031-5. (in Russ).
  31. Balakhnin P. V., Belyaеv A. M., Bagnenko S. S., Burovik I. A., Shmelev A. S. Flat-detector computed tomography technologies in interventional oncology: Diagnosis, staging and treatment of hepatocellular carcinoma. // High-tech medicine. 2023; 1(1): 6-25. (In Russ).
  32. Breder V. V., Bazin I. S., Balakhnin P. V., Virshke Je. R., Kosyrev V. Ju., Ledin E. V., Medvedeva B. M., Moiseenko F. V., Moroz E. A., Petkau V. V., Pokataev I. A. Zlokachestvennye opuholi pecheni i zhelchevyvodjashhej sistemy. // Zlokachestvennye opuholi. 2023. T. 13. № 3S2-1. S. 494-538. doi: 10.18027/2224-5057-2023-13-3s2-1-494-538. (in Russ).
  33. Balakhnin P. V., Shmelev A. S., Shachinov E. G. The role of surgical technologies in the treatment of virus-associated tumors on the example of hepatocellular carcinoma. // Prakticheskaja onkologija. 2018; 19(4): 348-377. (in Russ).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 76969 от 11.10.2019. 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies